10 Micro-, Small-Cap Firms Dominate Thursday’s Gains

Page 9 of 9

1. Impact Biomedical Inc. (NYSEAMERICAN:IBO)

Impact Biomedical soared by 292 percent on Thursday to end at $2.08 each following the appointment of Chan Heng Fai Ambrose as a director for the company.

With over 45 years in the financial and equity investment industry, Chan specializes in financial restructuring and focuses on investing in distressed companies that need corporate transformation.

His extensive background in restructuring firms and leadership roles in publicly listed firms is expected to enhance the strategic direction and governance of IBO.

Chan is the founder of Alset Inc., a Nasdaq-listed firm that specializes in land development, home building, sales and rental, and property management.

While we acknowledge the potential of IBO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as IBO but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9